Citations (42)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Angelo V. Marzano, Federica Dassoni & Ruggero Caputo. (2006) Treatment of refractory blistering autoimmune diseases with mycophenolic acid. Journal of Dermatological Treatment 17:6, pages 370-376.
Read now
Read now
Melissa A Magliocco. (2005) Emerging drugs for moderate-to-severe psoriasis. Expert Opinion on Emerging Drugs 10:1, pages 35-52.
Read now
Read now
Todd R. Gleaves, Jennifer Clay Cather & Alan Menter. (2005) Oral Erosions and Cutaneous Bullae. Baylor University Medical Center Proceedings 18:1, pages 71-73.
Read now
Read now
Articles from other publishers (39)
Ali Sadrolvaezin, Arezou Pezhman, Iman Zare, Shima Zahed Nasab, Sajad Chamani, Ali Naghizadeh & Ebrahim Mostafavi. (2023) Systemic allergic contact dermatitis to palladium, platinum, and titanium: mechanisms, clinical manifestations, prevalence, and therapeutic approaches. MedComm 4:6.
Crossref
Crossref
Gaetano Isola, Simona Santonocito, Rosalia Leonardi & Alessandro PolizziGaetano Isola, Simona Santonocito, Rosalia Leonardi & Alessandro Polizzi. 2023. Oral Lichen Planus and Lichenoid Lesions. Oral Lichen Planus and Lichenoid Lesions
187
230
.
Shelly Rivas & Allireza Alloo. 2022. Interdisciplinary Approaches to Overlap Disorders in Dermatology & Rheumatology. Interdisciplinary Approaches to Overlap Disorders in Dermatology & Rheumatology
271
281
.
Meysam Alizadeh-Kouzehrash & Abbas Rahmati. (2020) Solvent-free synthesis of isoindolo[2,1-c]pyrazolo[1,5-a]quinazoline and pyrazolo[5′,1′:2,3]pyrimido[6,1-a]isoindol derivatives through a one-pot three-component reaction. Molecular Diversity 25:2, pages 1123-1130.
Crossref
Crossref
Sheila Aidi, Maryam Daneshpazhooh, Masoud Eslami, Arghavan Azizpour, Roja Toosi & Reza Mollazadeh. (2020) Adverse electrocardiographic effects of rituximab infusion in pemphigus patients. Dermatologic Therapy 33:6.
Crossref
Crossref
Crispian Scully. 2016. Rook's Textbook of Dermatology, Ninth Edition. Rook's Textbook of Dermatology, Ninth Edition
1
144
.
Lisa Arkin, Sreya Talasila & Amy S. Paller. (2016) Mycophenolate Mofetil and Mood Changes in Children with Skin Disorders. Pediatric Dermatology 33:3.
Crossref
Crossref
Micole Tuchman, Jonathan I. Silverberg, Sharon E. Jacob & Nanette Silverberg. (2015) Nickel contact dermatitis in children. Clinics in Dermatology 33:3, pages 320-326.
Crossref
Crossref
Kristyn Deen & Erin McMeniman. (2015) Mycophenolate mofetil in erosive genital lichen planus: A case and review of the literature. The Journal of Dermatology 42:3, pages 311-314.
Crossref
Crossref
Sarah J Strathie Page & Clare P Tait. (2015) Mycophenolic acid in dermatology a century after its discovery. Australasian Journal of Dermatology 56:1, pages 77-83.
Crossref
Crossref
Matthew R. Smith & Sheldon C. Cooper. (2014) Mycophenolate mofetil therapy in the management of inflammatory bowel disease — A retrospective case series and review. Journal of Crohn's and Colitis 8:8, pages 890-897.
Crossref
Crossref
Jane Li, Alvin H Chong, Jack Green, Robert Kelly & Christopher Baker. (2013) Mycophenolate use in dermatology: A clinical audit. Australasian Journal of Dermatology 54:4, pages 296-302.
Crossref
Crossref
Jane Li & Robert Kelly. (2013) Treatment of pyoderma gangrenosum with mycophenolate mofetil as a steroid-sparing agent. Journal of the American Academy of Dermatology 69:4, pages 565-569.
Crossref
Crossref
George Liapis, John Boletis, Chrysanthi Skalioti, George Bamias, Katerina Tsimaratou, Efstratios Patsouris & Ioanna Delladetsima. (2013) Histological spectrum of mycophenolate mofetil-related colitis: association with apoptosis. Histopathology, pages n/a-n/a.
Crossref
Crossref
Juan Sebastián Segura Charry, Diego Alejandro Jaimes & John Darío Londoño. (2013) Pioderma gangrenoso refractario: utilidad de la terapia combinada. Enfoque en beneficio de la terapia hiperbárica en su tratamiento. Revista Colombiana de Reumatología 20:3, pages 171-176.
Crossref
Crossref
Hesham El Enshasy. 2011. Industrial Applications. Industrial Applications
165
194
.
Carlos A. Cañas, Carlos E. Durán, Juan C. Bravo, Dora E. Castaño & Gabriel J. Tobón. (2010) Leg ulcers in the antiphospholipid syndrome may be considered as a form of pyoderma gangrenosum and they respond favorably to treatment with immunosuppression and anticoagulation. Rheumatology International 30:9, pages 1253-1257.
Crossref
Crossref
C. Scully & A. Hegarty. 2010. Rook's Textbook of Dermatology. Rook's Textbook of Dermatology
1
129
.
Bryan K. Cho, Deborah Sah, Jennifer Chwalek, Ingrid Roseborough, Blanca Ochoa, Charles Chiang & Vera H. Price. (2010) Efficacy and safety of mycophenolate mofetil for lichen planopilaris. Journal of the American Academy of Dermatology 62:3, pages 393-397.
Crossref
Crossref
E Bulbul Baskan, M Yilmaz, S Tunali & H Saricaoglu. (2009) Efficacy and safety of long-term mycophenolate sodium therapy in pemphigus vulgaris. Journal of the European Academy of Dermatology and Venereology 23:12, pages 1432-1434.
Crossref
Crossref
Marlene T. Anderka, Angela E. Lin, Dianne N. Abuelo, Allen A. Mitchell & Sonja A. Rasmussen. (2009) Reviewing the evidence for mycophenolate mofetil as a new teratogen: Case report and review of the literature. American Journal of Medical Genetics Part A 149A:6, pages 1241-1248.
Crossref
Crossref
Crispian Scully & Lorenzo Lo Muzio. (2008) Oral mucosal diseases: Mucous membrane pemphigoid. British Journal of Oral and Maxillofacial Surgery 46:5, pages 358-366.
Crossref
Crossref
Efstathios Rallis & Vasileios Anyfantakis. (2008) Coexistent Psoriasis and Bullous Pemphigoid Responding to Mycophenolate Mofetil Monotherapy. SKINmed 7:2, pages 101-102.
Crossref
Crossref
Bonnie T. Mackool. 2008. Albert & Jakobiec's Principles & Practice of Ophthalmology. Albert & Jakobiec's Principles & Practice of Ophthalmology
3255
3262
.
F.J. Duncan, Brian C. Wulff, Kathleen L. Tober, Amy K. Ferketich, Jason Martin, Jennifer M. Thomas-Ahner, Stephanie D. Allen, Donna F. Kusewitt, Tatiana M. Oberyszyn & Anne M. VanBuskirk. (2007) Clinically Relevant Immunosuppressants Influence UVB-Induced Tumor Size Through Effects on Inflammation and Angiogenesis. American Journal of Transplantation 7:12, pages 2693-2703.
Crossref
Crossref
C. Gaudy-Marqueste. (2007) Autres immunosuppresseurs : azathioprine (Imurel®), mycophénolate mofétil (Cellcept®), cyclophosphamide (Endoxan®). Annales de Dermatologie et de Vénéréologie 134:12, pages 949-956.
Crossref
Crossref
Mauro Paradisi. 2007. La scuola dell’atopia. La scuola dell’atopia
209
222
.
H. Benchikhi, S. Ghafour, A. Disky, K. Janati, L. Bichra & H. Lakhdar. (2006) Pemphigus : modalités thérapeutiques et évolution de 122 cas. Annales de Dermatologie et de Vénéréologie 133:12, pages 1012-1014.
Crossref
Crossref
Margret Arnadottir, Eirikur Jonsson & Johann Jonsson. (2006) Inactivity of Hidradenitis Suppurativa After Renal Transplantation. Transplantation 82:6, pages 849.
Crossref
Crossref
Jolanda M. van Dieren, Ernst J. Kuipers, Janneke N. Samsom, Edward E. Nieuwenhuis & Janneke C. van der Woude. (2006) Revisiting the immunomodulators tacrolimus, methotrexate, and mycophenolate mofetil: Their mechanisms of action and role in the treatment of IBD. Inflammatory Bowel Diseases 12:4, pages 311-327.
Crossref
Crossref
A. Tirado-Sánchez & G. León-Dorantes. (2006) Treatment of pemphigus vulgaris. An overview in Mexico. Allergologia et Immunopathologia 34:1, pages 10-16.
Crossref
Crossref
J Bagan, LL Muzio & C Scully. (2005) Number III Mucous membrane pemphigoid. Oral Diseases 11:4, pages 197-218.
Crossref
Crossref
Daniel N. Sauder & Mona Z. Mofid. (2005) Topical Immunotherapy: What's New. Dermatologic Clinics 23:2, pages 245-258.
Crossref
Crossref
Gavin A.E. Wong & Neil H. Shear. (2005) Adverse Drug Interactions and Reactions in Dermatology: Current Issues of Clinical Relevance. Dermatologic Clinics 23:2, pages 335-342.
Crossref
Crossref
M Hartmann & A Enk. (2016) Mycophenolate mofetil and skin diseases. Lupus 14:3_suppl, pages 58-63.
Crossref
Crossref
P. Musette. (2005) Le mycophénolate : 30 ans après. Annales de Dermatologie et de Vénéréologie 132:1, pages 7-8.
Crossref
Crossref
M Hartmann & A Enk. (2016) Mycophenolate mofetil and skin diseases. Lupus 14:1_suppl, pages 58-63.
Crossref
Crossref
Daniel N. Sauder. (2005) Mechanism of Action and Emerging Role of Immune Response Modifier Therapy in Dermatologic Conditions. Journal of Cutaneous Medicine & Surgery 8:S3, pages 3-12.
Crossref
Crossref
David E. Cohen & Noushin Heidary. (2004) Treatment of irritant and allergic contact dermatitis. Dermatologic Therapy 17:4, pages 334-340.
Crossref
Crossref